BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 3981802)

  • 1. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases.
    Erkek B; Ozkan N; Bayar S; Genc V; Ekrem U; Kuzu A; Aribal D
    Hepatogastroenterology; 2007; 54(73):77-80. PubMed ID: 17419235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for colorectal cancer: a national problem].
    Faivre J; Bader JP
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):351-2. PubMed ID: 3435031
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal neoplasia in the Tel Aviv area: cumulative data 1979-89 and initial conclusions.
    Rozen P
    Isr J Med Sci; 1992 Jan; 28(1 Suppl):8-20. PubMed ID: 1733908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas.
    Winawer SJ; Sherlock P
    Cancer; 1982 Dec; 50(11 Suppl):2609-14. PubMed ID: 7139555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoccult screening for colorectal cancer in Missouri.
    Linne JH; Fulbeck CT; Butt JH; Huston JD; Butt MT; Jaco D
    Mo Med; 1983 Jun; 80(6):309-12. PubMed ID: 6877226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reducing incidence and mortality from rectal cancer by polypectomy: a prospective cohort study].
    Liu X; Zheng S; Zhang S; Ding X; Shen Y; Shen G; Sun Q; Li W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):245-8. PubMed ID: 11860790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is metabolic syndrome a risk factor for colorectal adenoma?
    Kim JH; Lim YJ; Kim YH; Sung IK; Shim SG; Oh SO; Park SS; Yang S; Son HJ; Rhee PL; Kim JJ; Rhee JC; Choi YH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1543-6. PubMed ID: 17684126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for colorectal neoplasms. A review and recommendations].
    Kronborg O
    Ugeskr Laeger; 1993 Oct; 155(41):3272-7. PubMed ID: 8256320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.